))
Fighting Cancer with CRISPR
Manage episode 419756344 series 3379085
Contenuto fornito da iHeartPodcasts and Pushkin Industries and Pushkin Industries. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da iHeartPodcasts and Pushkin Industries and Pushkin Industries o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Last year, the FDA approved a treatment for sickle cell disease using a revolutionary new gene editing technology called CRISPR. Rachel Haurwitz conducted pioneering research on CRISPR as a graduate student. Now she’s the co-founder and CEO of Caribou Biosciences. Rachel's problem is this: How can you improve CRISPR and use it to engineer human immune cells to fight cancer?
See omnystudio.com/listener for privacy information.
132 episodi
Condividi
